TEK and kidney disorder: Therefore, Tie2 may be a potential target for the treatment of this disease.<h4>Impact</h4>This is the first report to confirm that an agonistic Tie2 monoclonal antibody can reduce renal interstitial fibrosis in folic acid-induced nephropathy in mice.